Development and validation of RP-HPLC method for Empagliflozin and Metformin HCL
Abstract
A simple, specific and accurate RP-HPLC method was developed and validated for simultaneous determination of Empagliflozin and Metformin hydrochloride in bulk and Pharmaceutical dosage form. Chromatographic separation was carried out on Grace C18 column (250×4.6mm, 5µm), Methanol: Water pH 3.0 in the ratio of 80:20 % v/v, Flow rate is 0.8 ml/min and UV detection at 227nm.The Retention times of Empagliflozin and Metformin hydrochloride were found to be 2.630 min and 5.133min, respectively. The validation parameter studied were linearity, accuracy, precision, specificity and robustness i.e. pH of the mobile phase on the retention behavior. The proposed method was validated as per ICH guideline
Read the paper
Related studies
- The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
- Hypoglycemic medicines in the treatment of Alzheimer’s disease: Pathophysiological links between AD and glucose metabolism
- Isorhamnetin Reduces Glucose Level, Inflammation, and Oxidative Stress in High-Fat Diet/Streptozotocin Diabetic Mice Model
- Modulating Sirtuin Biology and Nicotinamide Adenine Diphosphate Metabolism in Cardiovascular Disease—From Bench to Bedside
- Characterization of the SGLT2 Interaction Network and Its Regulation by SGLT2 Inhibitors: A Bioinformatic Analysis
- Early Treatment with Empagliflozin and GABA Improves β-Cell Mass and Glucose Tolerance in Streptozotocin-Treated Mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.